Lilly (NYSE: LLY) affiliate reports multiple May 2026 share sales

Rhea-AI Filing Summary

Lilly Endowment Inc. reported multiple sales of Eli Lilly and Company common stock in May 2026. The filing lists specific transactions including 05/13/2026 sale of 256,365 shares for $259,024,427.96 and 05/21/2026 sale of 290,980 shares for $301,996,706.49.

Insights

Corporate Governance Analyst

Multiple large block sales by an affiliate are disclosed across May 2026.

The excerpt lists distinct sale dates and proceeds for an affiliate, including 05/13/2026 ($259,024,427.96) and 05/21/2026 ($301,996,706.49), which are material dollar amounts in single transactions.

These are reported dispositions by an affiliate; the excerpt does not state whether sales were part of a plan or the filer’s remaining holdings. Subsequent filings or a Form 4 may provide additional ownership context.

Key Figures

Sale on 05/13/2026: 256,365 shares Proceeds on 05/13/2026: $259,024,427.96 Sale on 05/21/2026: 290,980 shares +3 more

6 metrics

Sale on 05/13/2026 256,365 shares Sale reported for Eli Lilly stock on <date>05/13/2026</date>

Proceeds on 05/13/2026 $259,024,427.96 Proceeds from the 05/13/2026 sale

Sale on 05/21/2026 290,980 shares Sale reported for Eli Lilly stock on <date>05/21/2026</date>

Proceeds on 05/21/2026 $301,996,706.49 Proceeds from the 05/21/2026 sale

Sale on 05/06/2026 15,828 shares Sale reported for Eli Lilly stock on <date>05/06/2026</date>

Proceeds on 05/06/2026 $15,754,535.92 Proceeds from the 05/06/2026 sale

Key Terms

Form 144, affiliate, gift

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

affiliate financial

"Lilly Endowment Inc. listed as selling entity"

gift legal

"Common Stock | 02/10/1948 | Gift | J.K. Lilly Sr. Trust"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 383 Madison Avenue New York NY 10179	300000	312495000	941741406	05/22/2026	NYSE, NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/10/1948	Gift	J.K. Lilly Sr. Trust		01/21/1937	38400000		N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/06/2026	15828	15754535.92
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/11/2026	262	260690
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/12/2026	27545	27420659.12
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/13/2026	256365	259024427.96
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/20/2026	14020	14427122.57
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/21/2026	290980	301996706.49

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What sales does the LLY Form 144 disclose?

The filing discloses multiple May 2026 sales by Lilly Endowment Inc., including 256,365 shares on 05/13/2026 for $259,024,427.96 and 290,980 shares on 05/21/2026 for $301,996,706.49.

Who executed the transactions reported in the Form 144 for LLY?

The transactions are reported by Lilly Endowment Inc. as the selling entity, with an earlier reference to J.K. Lilly Sr. Trust; the excerpt lists the seller names and specific sale dates in May 2026.

How large were the single largest dispositions shown in the excerpt?

The largest reported single disposition in the excerpt is 290,980 shares sold on 05/21/2026 for $301,996,706.49, followed by 256,365 shares on 05/13/2026 for $259,024,427.96.

Does this Form 144 state remaining holdings or intent to sell more LLY shares?

The excerpt lists past sales and specific tranches but does not state remaining holdings or future sale intent. Further ownership context or planned sales are not provided in the provided text.